Arcus Biosciences, Inc. (RCUS) Financials

RCUS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.1 billion 633.0 million
2023-09-30 1.2 billion 671.0 million
2023-06-30 1.2 billion 654.0 million
2023-03-31 1.3 billion 654.0 million

RCUS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -94.0 million 18.0 million
2023-09-30 -73.0 million 18.0 million
2023-06-30 -62.0 million 18.0 million
2023-03-31 -101.0 million 19.0 million

RCUS Net Income

No data available :(

RCUS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 759.0 million - 11.0 million
2023-09-30 950.0 million - 9.0 million
2023-06-30 1.0 billion - -
2023-03-31 1.0 billion - -

RCUS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 74.0 million
2023-09-30 74.6 million
2023-06-30 73.2 million
2023-03-31 73.0 million

RCUS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 6.0 million 93.0 million 29.0 million -
2023-09-30 10.0 million 82.0 million 30.0 million -
2023-06-30 5.0 million 84.0 million 28.0 million -
2023-03-31 3.0 million 81.0 million 30.0 million -

RCUS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 31.0 million 5.0 million
2023-09-30 32.0 million 3.0 million
2023-06-30 29.0 million 4.0 million
2023-03-31 25.0 million 4.0 million

RCUS

Price: $15.23

52 week price:
12.95
25.47

Earnings Per Share: -4.15 USD

P/E Ratio: -3.83

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 965900

Market Capitalization: 1.6 billion

Links: